PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 160 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2017. The put-call ratio across all filers is 1.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $169,317 | -25.0% | 64,379 | +0.7% | 0.00% | – |
| Q2 2023 | $225,631 | -42.9% | 63,918 | -50.0% | 0.00% | – |
| Q1 2023 | $395,032 | +46.1% | 127,842 | +100.0% | 0.00% | – |
| Q4 2022 | $270,335 | +77.9% | 63,909 | -0.6% | 0.00% | – |
| Q3 2022 | $152,000 | -17.4% | 64,311 | -0.7% | 0.00% | – |
| Q2 2022 | $184,000 | -1.1% | 64,745 | +0.1% | 0.00% | – |
| Q1 2022 | $186,000 | +44.2% | 64,692 | +406.7% | 0.00% | – |
| Q3 2020 | $129,000 | -75.0% | 12,768 | -74.1% | 0.00% | – |
| Q2 2020 | $515,000 | -50.3% | 49,368 | -59.8% | 0.00% | – |
| Q1 2020 | $1,037,000 | -3.5% | 122,868 | 0.0% | 0.00% | – |
| Q4 2019 | $1,075,000 | -53.4% | 122,868 | -42.7% | 0.00% | – |
| Q3 2019 | $2,309,000 | -37.1% | 214,568 | -25.7% | 0.00% | – |
| Q2 2019 | $3,670,000 | -82.0% | 288,781 | -45.2% | 0.00% | -100.0% |
| Q1 2019 | $20,445,000 | +16.8% | 527,068 | -38.7% | 0.00% | 0.0% |
| Q4 2018 | $17,507,000 | -72.4% | 860,266 | -37.7% | 0.00% | -71.4% |
| Q3 2018 | $63,360,000 | -37.7% | 1,381,893 | -19.7% | 0.01% | -41.7% |
| Q2 2018 | $101,756,000 | -5.8% | 1,720,294 | +8.3% | 0.01% | -7.7% |
| Q1 2018 | $108,069,000 | -36.0% | 1,588,089 | -7.0% | 0.01% | -35.0% |
| Q4 2017 | $168,851,000 | -33.3% | 1,708,154 | -19.2% | 0.02% | -35.5% |
| Q3 2017 | $253,148,000 | +14.9% | 2,113,970 | -16.1% | 0.03% | +14.8% |
| Q2 2017 | $220,252,000 | +67.2% | 2,520,048 | -28.8% | 0.03% | +58.8% |
| Q1 2017 | $131,715,000 | +24.0% | 3,540,729 | +2.4% | 0.02% | +21.4% |
| Q4 2016 | $106,201,000 | -67.5% | 3,459,319 | -29.0% | 0.01% | -68.2% |
| Q3 2016 | $326,799,000 | +125.1% | 4,873,963 | 0.0% | 0.04% | +120.0% |
| Q2 2016 | $145,195,000 | +1.4% | 4,873,963 | +0.0% | 0.02% | 0.0% |
| Q1 2016 | $143,121,000 | -62.5% | 4,873,026 | +0.2% | 0.02% | -60.8% |
| Q4 2015 | $381,444,000 | +4.4% | 4,865,362 | +0.4% | 0.05% | -1.9% |
| Q3 2015 | $365,238,000 | -35.1% | 4,846,573 | +0.5% | 0.05% | -27.8% |
| Q2 2015 | $563,041,000 | -40.8% | 4,822,624 | +19.8% | 0.07% | -40.5% |
| Q1 2015 | $950,532,000 | +24.4% | 4,025,798 | -0.2% | 0.12% | +22.2% |
| Q4 2014 | $763,787,000 | +14.8% | 4,035,436 | +44.7% | 0.10% | +10.0% |
| Q3 2014 | $665,494,000 | +564.0% | 2,789,515 | +83.7% | 0.09% | +592.3% |
| Q2 2014 | $100,229,000 | -58.0% | 1,518,618 | -33.8% | 0.01% | -60.6% |
| Q1 2014 | $238,802,000 | -19.6% | 2,293,085 | -20.0% | 0.03% | -21.4% |
| Q4 2013 | $296,885,000 | +53.8% | 2,867,623 | -20.3% | 0.04% | +40.0% |
| Q3 2013 | $193,014,000 | +20.4% | 3,596,997 | -0.4% | 0.03% | +15.4% |
| Q2 2013 | $160,255,000 | – | 3,611,797 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVARD MANAGEMENT CO INC | 600,000 | $45,216,000 | 3.56% |
| Avalon Global Asset Management LLC | 32,900 | $2,479,000 | 1.79% |
| CORNERSTONE CAPITAL MANAGEMENT LLC | 495,145 | $37,314,000 | 1.58% |
| BB BIOTECH AG | 521,991 | $39,337,000 | 1.25% |
| WEATHERBIE CAPITAL, LLC | 137,041 | $10,327,000 | 1.20% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $428,527,000 | 1.19% |
| TOBAM | 318,384 | $23,994,000 | 0.94% |
| Orbimed Advisors | 1,195,500 | $90,093,000 | 0.91% |
| Capital International Sarl | 109,405 | $8,245,000 | 0.74% |
| CAPITAL INTERNATIONAL LTD /CA/ | 145,697 | $10,980,000 | 0.73% |